Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

Shakoora Sabree, M6G

shakoora-sabree@uiowa.edu

 

MSTP Learning Community:  McCowen

MSTP Entry Date:  June 6, 2016

PhD Program:

Immunology

Mentor:

George Weiner, MD, PhD


Evaluating the Complexity of the Immune Response to Vidutolimod, a Virus-Like Particle Containing a TLR9 Agonist

Thesis Defense:  October 22, 2021


Committees:

2016-2018 - Student National Medical Association, UI Mentorship Chair

2016-2018 - MSTP Applicant Task Force

2018-2019 - MSTP Wellness Committee

2018-2020 - MSTP Admissions Committee Member

2018-present - MSTP Monday Committee

Awards:

2016 - Sloan Scholar

2018 - 3rd Place, Carol A Bowman Creative Writing Contest "When Rivers Run Dry"

2018-2022 NIH Diversity Supplement

Teaching:

2019 Fall - M2 MOHD IV Lab Teaching Assistant

Education:

2016 - BS, Biochemistry & Molecular Biology - Agnes Scott College

Publications:

ORCiD: 0000-0001-8392-2112

Sabree S, Berg D, Sato M. Treatment of a pediatric patient with MET-amplified signet ring cell adenocarcinoma of the stomach with crizotinib. Pediatr Blood Cancer. 2018 Jun;65(6):e26984. doi: 10.1002/pbc.26984. Epub 2018 Jan 30. PubMed PMID: 29380521.

Sabree SA, Voigt AP, Blackwell SE, Vishwakarma A, Chimenti MS, Salem AK, Weiner GJ. Direct and indirect immune effects of CMP-001, a virus-like particle containing a TLR9 agonist. J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002484. PubMed PMID: 34083419; PubMed Central PMCID: PMC8183212.

Sabree SA, Lemke-Miltner CD, Blackwell SE, Yin C, Bossler A, Ebeid K, Salem AK, Weiner GJ. Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to Vidutolimod. Vaccines (Basel). 2021 Sep 2;9(9). doi: 10.3390/vaccines9090982. PubMed PMID: 34579220; PubMed Central PMCID: PMC8473335.

Hornick EL, Stunz LL, Sabree S, Wu X, Witzig TE, Bishop GA. The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 Inhibition. Cancers (Basel). 2022 Oct 14;14(20):5029. doi: 10.3390/cancers14205029. PMID: 36291813; PMCID: PMC9599470.